Related Experiment Video
Updated: Jul 2, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Neurologic damage and neurocognitive dysfunction in urea cycle disorders
1Department of Pediatrics, Division of Medical Genetics, Lucile Packard Children's Hospital, Stanford University, Stanford, CA 94305, USA. greg.enns@stanford.edu
Seminars in Pediatric Neurology
|August 19, 2008
Summary
Survival in urea cycle disorders has improved, but neurologic outcomes remain poor. Research is exploring brain dysfunction causes like glutamine, mitochondrial issues, and neurotransmitter changes to develop better therapies.
Area of Science:
- Biochemistry
- Neurology
- Genetics
Background:
- Urea cycle disorders (UCDs) are genetic metabolic conditions.
- Improved survival due to treatments like alternative pathway therapy and hemodialysis.
- Neurologic outcomes remain suboptimal in patients with UCDs.
Purpose of the Study:
- To review current understanding of brain dysfunction in UCDs.
- To explore pathogenetic mechanisms contributing to neurologic abnormalities.
- To identify potential therapeutic targets for improving brain health in UCDs.
Main Methods:
- Review of existing literature on UCDs and neurologic complications.
- Analysis of hypotheses regarding the pathogenesis of brain dysfunction.
- Synthesis of current research on molecular mechanisms.
Main Results:
- Patients with UCDs frequently experience cerebral edema, seizures, cognitive impairment, and psychiatric issues.
- Key pathogenetic hypotheses include glutamine-induced cerebral edema, mitochondrial dysfunction, and altered neurotransmitter metabolism.
- Understanding these mechanisms is crucial for developing targeted therapies.
Conclusions:
- Neurologic complications significantly impact quality of life in UCD patients.
- Further research into the molecular pathways of brain dysfunction is warranted.
- Advances in understanding pathogenesis may lead to novel therapeutic strategies for UCDs.
Related Concept Videos
01:23Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...